Novel highly potent serotonin 5-HT7 receptor ligands: structural modifications to improve pharmacokinetic properties.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Bioorganic & Medicinal Chemistry Letters

• Publication date

  2013-11-15

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.bmcl.2013.09.025PMID 24100077
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Towards metabolically stable 5-HT7 receptor ligands: a study on 1-arylpiperazine derivatives and related isosters

  2013cited by this paper
• The serotonin receptor 7 promotes neurite outgrowth via ERK and Cdk5 signaling pathways.

  2013cited by this paper
• Investigations on the 1-(2-biphenyl)piperazine motif: identification of new potent and selective ligands for the serotonin(7) (5-HT(7)) receptor with agonist or antagonist action in vitro or ex vivo.

  2012cited by this paper
• Modulatory effects of two novel agonists for serotonin receptor 7 on emotion, motivation and circadian rhythm profiles in mice.

  2012cited by this paper
• Activation of 5-HT7 serotonin receptors reverses metabotropic glutamate receptor-mediated synaptic plasticity in wild-type and Fmr1 knockout mice, a model of Fragile X syndrome.

  2012cited by this paper
• Structural modifications that alter the P-glycoprotein efflux properties of compounds.

  2012cited by this paper
• 5-HT7R/G12 Signaling Regulates Neuronal Morphology and Function in an Age-Dependent Manner

  2012cited by this paper
• Role of the 5-HT7 Receptor in the Central Nervous System: from Current Status to Future Perspectives

  2011cited by this paper
• Pharmacological Blockade of 5-HT7 Receptors as a Putative Fast Acting Antidepressant Strategy

  2011cited by this paper
• Serotonin 5-HT7 receptor agents: Structure-activity relationships and potential therapeutic applications in central nervous system disorders.

  2011cited by this paper
• LP-211 is a brain penetrant selective agonist for the serotonin 5-HT(7) receptor.

  2010cited by this paper
• Methylphenidate to adolescent rats drives enduring changes of accumbal Htr7 expression: implications for impulsive behavior and neuronal morphology

  2009cited by this paper
• Therapeutic potential of 5-HT7 receptors in mood disorders.

  2009cited by this paper
• Structural modifications of N-(1,2,3,4-tetrahydronaphthalen-1-yl)-4-aryl-1-piperazinehexanamides: influence on lipophilicity and 5-HT7 receptor activity. Part III.

  2008cited by this paper
• Structure-activity relationship study on N-(1,2,3,4-tetrahydronaphthalen-1-yl)-4-aryl-1-piperazinehexanamides, a class of 5-HT7 receptor agents. 2.

  2007cited by this paper
• The conduct of drug metabolism studies considered good practice (II): in vitro experiments.

  2007cited by this paper
• Enhancement of the anti-immobility action of antidepressants by a selective 5-HT7 receptor antagonist in the forced swimming test in mice.

  2007cited by this paper
• N-dealkylation of arylpiperazine derivatives: disposition and metabolism of the 1-aryl-piperazines formed.

  2007cited by this paper
• Effect of the selective 5-HT7 receptor antagonist SB 269970 in animal models of anxiety and depression.

  2006cited by this paper
• 5-HT7 receptor inhibition and inactivation induce antidepressantlike behavior and sleep pattern.

  2005cited by this paper
• Structure-affinity relationship study on N-(1,2,3,4-tetrahydronaphthalen-1-yl)-4-aryl-1-piperazinealkylamides, a new class of 5-hydroxytryptamine7 receptor agents.

  2004cited by this paper
• Studies on 1‐arylpiperazine derivatives with affinity for rat 5‐HT7 and 5‐HT1A receptors

  2004cited by this paper
• Neuropsychopharmacology

  2003cited by this paper
• Synthesis and structure-affinity relationships of 1-[omega-(4-aryl-1-piperazinyl)alkyl]-1-aryl ketones as 5-HT(7) receptor ligands.

  2003cited by this paper
• Effects of Antidepressants on 5-HT7 Receptor Regulation in the Rat Hypothalamus

  1999cited by this paper
• Neuropharmacology

  1958cited by this paper

• Development and challenges in the discovery of 5-HT1A and 5-HT7 receptor ligands.

  2022cites this paper
• Structure-activity relationships of serotonin 5-HT7 receptors ligands: A review.

  2019cites this paper
• Structure-Activity Relationships and Therapeutic Potentials of 5-HT7 Receptor Ligands: An Update.

  2018cites this paper
• 1 Structure − Activity Relationships and Therapeutic Potentials of 5 ‑ HT 7 2 Receptor Ligands: An Update

  2018cites this paper
• How to Choose the Suitable Template for Homology Modelling of GPCRs: 5‐HT7 Receptor as a Test Case

  2016cites this paper
• Structural modifications of the serotonin 5-HT7 receptor agonist N-(4-cyanophenylmethyl)-4-(2-biphenyl)-1-piperazinehexanamide (LP-211) to improve in vitro microsomal stability: A case study.

  2016cites this paper
• 5-HT7 receptor activation: procognitive and antiamnesic effects

  2014cites this paper